Product Information Database

This website contains current information about veterinary medicines authorised in Great Britain and Northern Ireland.

Product details are subject to change. Once approved by the VMD, updated Summary of Product Characteristics (SPCs) and label text will be available here almost immediately; however, it can normally take 6-12 months for these approved changes to appear on marketed packaging. If you are concerned about any differences seen, please contact the Authorisation / Registration holder or VMD for clarification.

Currently authorised products - Details of all products subject of a valid marketing authorisation (MA). Please note – just because a product is authorised, doesn’t mean it is marketed. To find out if a product is marketed, please contact the MA holder.

Registered homeopathics - Details of all remedies subject of a valid registration. Under this simplified registration scheme applicants are not required to provide efficacy data, so the public assessment report will not cover this. Please note - just because a remedy is registered, it doesn’t mean that it is marketed. To find out if a remedy is marketed, please contact the registration holder.

Expired products - Details of all products and homeopathic remedies that are no longer subject of a valid authorisation / registration. Products and remedies that were released by the Qualified Person (‘QP released’) on or before the date of expiry may be placed / remain on the market.

Suspended products - Details about authorisations / registrations that have been temporarily suspended. Products / remedies that were released by the Qualified Person (‘QP released’) on or before the date of suspension may be placed / remain on the market.

Refused Applications - Details of applications for new marketing authorisations, homeopathic registrations, variation-extensions, and Type II variations that have been refused by the VMD.

Specified Feed Additives (inc. expired) - Details of authorised and expired Specified Feed Additives.

From 1st January 2021

From 1st January 2021, products will be authorised separately in Great Britain and Northern Ireland. The authorisations may be aligned if they are for the same product, meaning they:

• are the same pharmaceutical form
• have the same qualitative and quantitative composition
• are intended for the same target species with the same or similar indications
• have a shared dossier; except for certain differences that make no impact on the scientific requirements or regulatory framework such as sites of batch release

However, products authorised via a national application route prior to 1st January 2021 will still be subject of a UK-wide authorisation whilst they remain the same. Please see VMD Information Hub for more information.

Please note that for some products originally authorised under an EU procedure and converted to a Great Britain and/or Northern Ireland authorisation on the 1st January 2021, a UK Public Assessment Report (UKPAR) may not be immediately available. We will endeavour to populate this information over time.

Products that meet the criteria for unfettered market access to Great Britain will be supplied with the labels approved for Northern Ireland. These products are highlighted with the UMA icon.

Search

Help to search

Report a problem